Cargando…

“DOST” Model to Link and Support Drug Resistant TB Patients From Private Sector: An Experience From Delhi, India

BACKGROUND: The National TB Elimination Programme (NTEP) has quite successfully involved private sector for referral of presumptive drug resistant TB (DR-TB) patients for molecular testing and referral for DR-TB management. There was a challenge as all the referred patients were not reaching to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Vatsyayan, Vindhya, Pattery, Theresa, Sayyad, Khasim, Williams, Jason, Pal, Arnab, Panibatla, Vikas, Khanna, Ashwani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131023/
https://www.ncbi.nlm.nih.gov/pubmed/35646807
http://dx.doi.org/10.3389/fpubh.2022.835055
_version_ 1784713098387521536
author Vatsyayan, Vindhya
Pattery, Theresa
Sayyad, Khasim
Williams, Jason
Pal, Arnab
Panibatla, Vikas
Khanna, Ashwani
author_facet Vatsyayan, Vindhya
Pattery, Theresa
Sayyad, Khasim
Williams, Jason
Pal, Arnab
Panibatla, Vikas
Khanna, Ashwani
author_sort Vatsyayan, Vindhya
collection PubMed
description BACKGROUND: The National TB Elimination Programme (NTEP) has quite successfully involved private sector for referral of presumptive drug resistant TB (DR-TB) patients for molecular testing and referral for DR-TB management. There was a challenge as all the referred patients were not reaching to the facilities. A “DOST” intervention model was implemented to strengthen the patient care pathway. We conducted this study to describe the patient care cascade, the clinico-demographic characteristics of patients linked to the treatment and to estimate the mean turn-around time for drug resistant TB care services. METHODS: It is a cross-sectional study conducted at New Delhi during the period July 2019-December 2020 under programmatic settings. RESULTS: A total of 9,331 patients were subjected to CB-NAAT test and 382 (4%) were found to be resistant for rifampicin and 231 (76%) were initiated on treatment in the public sector under NTEP. CONCLUSION: The DOST intervention model developed to link the DR-TB patients from private sector to the public sector DR-TB centers is found to be efficient and effective.
format Online
Article
Text
id pubmed-9131023
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-91310232022-05-26 “DOST” Model to Link and Support Drug Resistant TB Patients From Private Sector: An Experience From Delhi, India Vatsyayan, Vindhya Pattery, Theresa Sayyad, Khasim Williams, Jason Pal, Arnab Panibatla, Vikas Khanna, Ashwani Front Public Health Public Health BACKGROUND: The National TB Elimination Programme (NTEP) has quite successfully involved private sector for referral of presumptive drug resistant TB (DR-TB) patients for molecular testing and referral for DR-TB management. There was a challenge as all the referred patients were not reaching to the facilities. A “DOST” intervention model was implemented to strengthen the patient care pathway. We conducted this study to describe the patient care cascade, the clinico-demographic characteristics of patients linked to the treatment and to estimate the mean turn-around time for drug resistant TB care services. METHODS: It is a cross-sectional study conducted at New Delhi during the period July 2019-December 2020 under programmatic settings. RESULTS: A total of 9,331 patients were subjected to CB-NAAT test and 382 (4%) were found to be resistant for rifampicin and 231 (76%) were initiated on treatment in the public sector under NTEP. CONCLUSION: The DOST intervention model developed to link the DR-TB patients from private sector to the public sector DR-TB centers is found to be efficient and effective. Frontiers Media S.A. 2022-05-11 /pmc/articles/PMC9131023/ /pubmed/35646807 http://dx.doi.org/10.3389/fpubh.2022.835055 Text en Copyright © 2022 Vatsyayan, Pattery, Sayyad, Williams, Pal, Panibatla and Khanna. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Vatsyayan, Vindhya
Pattery, Theresa
Sayyad, Khasim
Williams, Jason
Pal, Arnab
Panibatla, Vikas
Khanna, Ashwani
“DOST” Model to Link and Support Drug Resistant TB Patients From Private Sector: An Experience From Delhi, India
title “DOST” Model to Link and Support Drug Resistant TB Patients From Private Sector: An Experience From Delhi, India
title_full “DOST” Model to Link and Support Drug Resistant TB Patients From Private Sector: An Experience From Delhi, India
title_fullStr “DOST” Model to Link and Support Drug Resistant TB Patients From Private Sector: An Experience From Delhi, India
title_full_unstemmed “DOST” Model to Link and Support Drug Resistant TB Patients From Private Sector: An Experience From Delhi, India
title_short “DOST” Model to Link and Support Drug Resistant TB Patients From Private Sector: An Experience From Delhi, India
title_sort “dost” model to link and support drug resistant tb patients from private sector: an experience from delhi, india
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131023/
https://www.ncbi.nlm.nih.gov/pubmed/35646807
http://dx.doi.org/10.3389/fpubh.2022.835055
work_keys_str_mv AT vatsyayanvindhya dostmodeltolinkandsupportdrugresistanttbpatientsfromprivatesectoranexperiencefromdelhiindia
AT patterytheresa dostmodeltolinkandsupportdrugresistanttbpatientsfromprivatesectoranexperiencefromdelhiindia
AT sayyadkhasim dostmodeltolinkandsupportdrugresistanttbpatientsfromprivatesectoranexperiencefromdelhiindia
AT williamsjason dostmodeltolinkandsupportdrugresistanttbpatientsfromprivatesectoranexperiencefromdelhiindia
AT palarnab dostmodeltolinkandsupportdrugresistanttbpatientsfromprivatesectoranexperiencefromdelhiindia
AT panibatlavikas dostmodeltolinkandsupportdrugresistanttbpatientsfromprivatesectoranexperiencefromdelhiindia
AT khannaashwani dostmodeltolinkandsupportdrugresistanttbpatientsfromprivatesectoranexperiencefromdelhiindia